Zhengping Wang

Title: Innovations of Zhengping Wang in Liposomal Compositions

Introduction

Zhengping Wang is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of liposomal compositions that enhance the therapeutic efficacy of peptide epoxyketone compounds.

Latest Patents

Wang holds a patent for "Liposomal compositions of epoxyketone-based proteasome inhibitors." This patent describes liposomal compositions comprising peptide epoxyketone compounds, along with methods for their production and application. The innovation focuses on improving the in vivo half-life of these compounds compared to non-liposomal alternatives. The liposomal compositions not only provide desirable pharmacodynamic profiles but also demonstrate anti-tumor activity in human tumor xenograft models. Furthermore, the experiments supporting this invention indicate improved tolerability of these liposomal formulations.

Career Highlights

Zhengping Wang is associated with Onyx Therapeutics, Inc., where he continues to advance research in therapeutic innovations. His work has been pivotal in enhancing the understanding and application of proteasome inhibitors in cancer treatment.

Collaborations

Wang collaborates with esteemed colleagues, including Katherine A Chu and Elena T Chan, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Zhengping Wang's contributions to liposomal compositions represent a significant advancement in the field of cancer therapeutics. His innovative work continues to pave the way for improved treatment options for patients.